Overcoming Immunological Resistance Enhances the Efficacy of a Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal Adenocarcinoma
Mahboubeh Yazdanifar(University of North Carolina at Charlotte), Pinku Mukherjee(University of North Carolina at Charlotte)
Cited by 61
Related Papers
MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes
|Oncogenesis|2013|174
Overcoming Immunological Resistance Enhances the Efficacy of a Novel anti-tMUC1 CAR T Cell Treatment Against Pancreatic Ductal Adenocarcinoma
|bioRxiv (Cold Spring Harbor Laboratory)|2019|22
Mucin-1–Targeted Chimeric Antigen Receptor T Cells Are Effective and Safe in Controlling Solid Tumors in Immunocompetent Host
|Journal of Immunotherapy|2024|15
Molecular crosstalk between MUC1 and STAT3 influences the anti-proliferative effect of Napabucasin in epithelial cancers
|Scientific Reports|2024|7
Overexpression of MUC1 influences the anti-proliferative effect of STAT3-inhibitor Napabucasin in epithelial cancers
|bioRxiv (Cold Spring Harbor Laboratory)|2023|0